Jobs
-
Approximately 550 OINDP specialists attended RDD 2018 in Tucson, Arizona, where much of the interest centered around regulatory issues, especially in light of the FDA’s recent release of a revised draft guidance on MDI and… Read more . . .
-
Leading diabetes research funder JDRF has awarded a 2-year $525,000 grant to International Diabetes Center (IDC) to support a study of intranasal insulin in Type 1 diabetes patients with hypoglycemia unawareness, the first time that… Read more . . .
-
Posted on OINDPnews on May 2, 2018. Job postings may or may not be removed from the site after the position is filled. Catalent, Morrisville, NC, USA Position Summary The role supports Catalent’s Inhalation product… Read more . . .
-
Avadel Pharmaceuticals has announced the launch of Noctiva desmopressin nasal spray for the treatment of nocturia due to nocturnal polyuria (overproduction of urine at night) in adults. Avadel acquired US and Canadian rights to Noctiva… Read more . . .
-
Smartinhaler maker Adherium has announced a collaboration with pulmonary disease management provider Vitalus Health for promotion of Adherium’s inhaler monitoring technology to COPD patients in the southwest US. In September 2017, Adherium’s SmartTouch sensor received… Read more . . .
-
Clement Clarke International has announced the availability of a new smartphone app called the Trainhaler Buddy for use with its Trainhaler device to teach patients correct inhaler use technique. The Trainhaler Buddy app uses animations… Read more . . .
-
Submit abstracts for oral and poster presentations by 13 July 2018 at https://aerosol-soc.com/abstract-submission/ Abstract guidelines can be found at https://aerosol-soc.com/assets/uploads/2018/04/DDL-Abstract-Guidelines-2018.doc Themes for DDL2018 are: Insights in respiratory medicine – New therapeutic opportunities for treating asthma,… Read more . . .
-
The US Federal Trade Commission (FTC) is requiring Impax to divest several products in order to complete a planned merger with Amneal that the companies announced in October 2017. To satisfy the FTC requirements, Impax… Read more . . .
-
Mundipharma’s k-haler breath-activated metered dose inhaler has won two platinum A’ Design Awards in the ‘Scientific Instruments, Medical Devices and Research Equipment Design’ and ‘Ease of Use and Universal Design’ categories. In October 2017, the… Read more . . .
-
MannKind Corporation has announced that FDA is no longer requiring a Risk Evaluation and Mitigation Strategy (REMS) communication plan for Afrezza inhaled insulin. Afrezza was approved in the US in June 2014, with the FDA… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK